secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2026-04-24T23:59:59+00:00
Accession:  0001809519-26-000080
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx appoints Thomas Chan as Chief Accounting Officer effective April 23, 2026
--------------------------------------------------------------------------------

- Thomas Chan, previously VP Corporate Controller, named Chief Accounting Officer and principal accounting officer.
- Annual base salary increased to $310,000 with target bonus of 40% of base salary.
- Granted RSU award valued at $131,250 and PSU award valued at $43,750 under 2020 Incentive Award Plan.
- Chan joined GoodRx in October 2020 and is a CPA with prior experience at Deloitte & Touche.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000180951926000080/0001809519-26-000080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000180951926000080/gdrx-20260423.htm
  HTML page:      https://secwatch.observer/filing/0001809519-26-000080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer